Standard Dental Labs Inc (TUTH) Fair Value & Analysis
Healthcare · US · Market cap $6.9M
Standard Dental Labs Inc
TUTH · US
Risks
Fair value as of: Aug 23, 2026
From 1 valuation models · updated today
Share price −2.0% over the past month.
A solid business, currently priced close to our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 23, 2026.
How to read this chart
60‑month range $0.0202 – $8.57 · fair‑value band $0.0703 – $0.1099 · the $0.0990 price screens above the $0.0901 fair value. Dashed = 300-day average. As of Aug 23, 2026.
Analysis
Standard Dental Labs Inc (TUTH) currently trades at $0.0990, while our model-based Fair Value estimate is $0.0901, implying the stock looks roughly 9.0% fairly valued today. The Quality Score stands at 50/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at $236K. Revenue declined 49.2% year over year. Net debt stands at $1.6M. Fundamentals as of Aug 23, 2026
Our scenario range runs from $0.0703 (bear case) to $0.1099 (bull case); at $0.0990, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at -9%, TUTH screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when TUTH reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 48 · Market factors (momentum, volatility) 33
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Standard Dental Labs Inc., a dental laboratory company, manufactures dental products in Florida. It offers dental implants, crowns, bridges, veneers, and dentures. The company was incorporated in 1998 and is based in Orlando, Florida.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2013 – FY2023 · reported fiscal years
Standard Dental Labs Inc reported revenue of $339K in FY2023 versus $13.4K in FY2013, a compound +38.2%/yr. Reported net income was −$412K in FY2023.
Watch TUTH: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 205 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $378.81 | $150.04 | -60% |
| EssilorLuxottica Société anonyme 1EL | €164.40 | €68.55 | -58% |
| Medline Inc MDLN | $35.50 | $30.15 | -15% |
| Becton, Dickinson and Company BDX | $182.09 | $100.46 | -45% |
| Alcon Inc ALC | $73.58 | $39.78 | -46% |
| ResMed Inc RMD | $231.52 | $187.89 | -19% |
| West Pharmaceutical Services, Inc WST | $352.29 | $141.58 | -60% |
| Sartorius Stedim Biotech S.A DIM | €180.30 | €48.88 | -73% |
| Coloplast A/S COLOB | kr 435.80 | kr 382.22 | -12% |
| Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 | ¥77.48 | ¥27.22 | -65% |
Compare Standard Dental Labs Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Standard Dental Labs Inc (TUTH) overvalued or undervalued?
What is the fair value of TUTH?
What is the quality score of TUTH?
What is the revenue of Standard Dental Labs Inc (TUTH)?
What is the net profit margin of TUTH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Standard Dental Labs Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.